Risks and benefits of lifelong antiretroviral treatment for pregnant and breastfeeding women: a review of the evidence for the Option B+ approach
S Ahmed, MH Kim, EJ Abrams - Current Opinion in HIV and AIDS, 2013 - journals.lww.com
Risks and benefits of lifelong antiretroviral treatment for... : Current Opinion in HIV and AIDS
Risks and benefits of lifelong antiretroviral treatment for pregnant and breastfeeding women: a …
Risks and benefits of lifelong antiretroviral treatment for pregnant and breastfeeding women: a …
Alarming increase in pretreatment HIV drug resistance in children living in sub-Saharan Africa: a systematic review and meta-analysis
RS Boerma, KCE Sigaloff, AS Akanmu… - Journal of …, 2017 - academic.oup.com
Background: Children have an augmented risk of pretreatment HIV drug resistance (PDR)
due to exposure to antiretroviral drugs for the prevention of mother-to-child transmission …
due to exposure to antiretroviral drugs for the prevention of mother-to-child transmission …
Multicenter initial guidance on use of antivirals for children with coronavirus disease 2019/severe acute respiratory syndrome coronavirus 2
K Chiotos, M Hayes, DW Kimberlin… - Journal of the …, 2020 - academic.oup.com
Background Although coronavirus disease 2019 (COVID-19) is mild in nearly all children, a
small proportion of pediatric patients develop severe or critical illness. Guidance is therefore …
small proportion of pediatric patients develop severe or critical illness. Guidance is therefore …
Early time-limited antiretroviral therapy versus deferred therapy in South African infants infected with HIV: results from the children with HIV early antiretroviral (CHER) …
Background Interim results from the children with HIV early antiretroviral (CHER) trial
showed that early antiretroviral therapy (ART) was life-saving for infants infected with HIV. In …
showed that early antiretroviral therapy (ART) was life-saving for infants infected with HIV. In …
Suboptimal viral suppression rates among HIV-infected children in low-and middle-income countries: a meta-analysis
RS Boerma, TS Boender, AP Bussink… - Clinical infectious …, 2016 - academic.oup.com
Background The 90-90-90 goal to achieve viral suppression in 90% of all human
immunodeficiency virus (HIV)–infected people on antiretroviral treatment (ART) is especially …
immunodeficiency virus (HIV)–infected people on antiretroviral treatment (ART) is especially …
Paediatric E uropean N etwork for T reatment of AIDS (PENTA) guidelines for treatment of paediatric HIV‐1 infection 2015: optimizing health in preparation for adult life
A Bamford, A Turkova, H Lyall, C Foster, N Klein… - HIV …, 2018 - Wiley Online Library
The 2015 Paediatric E uropean Network for Treatment of AIDS (PENTA) guidelines provide
practical recommendations on the management of HIV‐1 infection in children in E urope and …
practical recommendations on the management of HIV‐1 infection in children in E urope and …
[HTML][HTML] Routine versus clinically driven laboratory monitoring and first-line antiretroviral therapy strategies in African children with HIV (ARROW): a 5-year open-label …
ARROW Trial Team - The Lancet, 2013 - Elsevier
BACKGROUND: No trials have investigated routine laboratory monitoring for children with
HIV, nor four-drug induction strategies to increase durability of first-line antiretroviral therapy …
HIV, nor four-drug induction strategies to increase durability of first-line antiretroviral therapy …
Neuropsychological performance in African children with HIV enrolled in a multisite antiretroviral clinical trial
MJ Boivin, L Barlow-Mosha, MC Chernoff, B Laughton… - Aids, 2018 - journals.lww.com
Objective and design: Children with HIV infection (HIV+) are at neuropsychological risk, but
few studies have evaluated this at multiple sites in low-income and middle-income countries …
few studies have evaluated this at multiple sites in low-income and middle-income countries …
The nucleoside reverse transcriptase inhibitors, nonnucleoside reverse transcriptase inhibitors, and protease inhibitors in the treatment of HIV infections (AIDS)
E De Clercq - Advances in pharmacology, 2013 - Elsevier
The majority of the drugs currently used for the treatment of HIV infections (AIDS) belong to
either of the following three classes: nucleoside reverse transcriptase inhibitors (NRTIs) …
either of the following three classes: nucleoside reverse transcriptase inhibitors (NRTIs) …
Characterization of drug authenticity using thin-layer chromatography imaging with a mobile phone
Thin-layer chromatography (TLC) has a myriad of separation applications in chemistry,
biology, and pharmacology due to its simplicity and low cost. While benchtop laboratory …
biology, and pharmacology due to its simplicity and low cost. While benchtop laboratory …